The North Carolina Business Court recently issued a ruling in the case of Innovare, Ltd. v. Sciteck Diagnostics, Inc., which centers around a business dispute between the two companies. The court's decision affects how Innovare and Sciteck will move forward in their business relationship, particularly concerning the distribution of a COVID-19 testing product called SalivaQuik. This ruling is significant as it clarifies certain contractual obligations and disputes that have arisen since the companies began working together.

Innovare, a consulting and software development company based in Nevada, and Sciteck, a Delaware corporation that produces biological testing supplies, have been in a legal battle since Innovare filed a complaint in Henderson County Superior Court on December 6, 2021. The dispute arose from a series of agreements and misunderstandings regarding the distribution and use of Sciteck's SalivaQuik test, a rapid COVID-19 testing device developed during the pandemic. The case was assigned docket number 21-CVS-2180.

The parties had initially entered into a Distributor Agreement on February 18, 2021, which was meant to formalize their business relationship. However, as the court noted, the agreement was not particularly clear, leading to differing interpretations of its terms. Innovare claimed it had the right to distribute SalivaQuik, while Sciteck contended that Innovare was breaching the agreement by allowing the product to be used for purposes not permitted under FDA regulations.

As the case progressed, both companies filed motions for partial summary judgment, seeking to resolve certain claims without going to trial. The court reviewed these motions, along with the arguments presented by both parties, and ultimately issued a combined opinion on May 29, 2024.

In its ruling, the court granted in part and denied in part both Innovare's and Sciteck's motions for partial summary judgment. Specifically, the court stated, "This case ultimately cries out for resolution by a jury, but the Court must first separate those claims that fail as a matter of law from those claims that require resolution at trial." This indicates that while some issues can be resolved legally, others will need to be addressed in a jury trial.

Judge Mark A. Davis presided over the case and emphasized the importance of clarifying the parties' rights and obligations under the Distributor Agreement. The court's decision highlighted the ongoing disagreements between Innovare and Sciteck regarding their business relationship and the distribution of SalivaQuik. The court noted that the relationship had become increasingly complicated, with both sides presenting conflicting narratives about their interactions.

As part of the ruling, the court also addressed Sciteck's motion for judgment on the pleadings, which was denied as moot. This means that the court found it unnecessary to rule on that motion because the other issues were still active and unresolved.

The impact of this ruling is significant for both companies. It clarifies that while some claims may not proceed to trial, others will, potentially leading to a jury's determination on the disputed issues. This decision may also influence how Innovare and Sciteck conduct their business moving forward, especially regarding the distribution of SalivaQuik and compliance with FDA regulations.

Going forward, the court's ruling sets the stage for a potential jury trial, where the unresolved claims can be fully examined. This could have lasting implications for both companies, particularly in terms of their contractual obligations and business strategies. The ruling may also serve as a precedent for similar disputes in the future, particularly in the context of business agreements that involve complex regulatory compliance issues.

As of now, it is unclear whether either party plans to appeal the court's ruling. The court filing did not provide details on any related cases pending or any further actions that may be taken by Innovare or Sciteck. The outcome of this case will likely continue to evolve as the parties seek to resolve their differences in court.